STOCK TITAN

United Therapeutics Corp - UTHR STOCK NEWS

Welcome to our dedicated news page for United Therapeutics (Ticker: UTHR), a resource for investors and traders seeking the latest updates and insights on United Therapeutics.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect United Therapeutics's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of United Therapeutics's position in the market.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.07%
Tags
conferences
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.74%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.73%
Tags
earnings
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.57%
Tags
conferences
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.14%
Tags
acquisition
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.24%
Tags
acquisition
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.26%
Tags
conferences earnings
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.84%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.47%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.2%
Tags
conferences
United Therapeutics Corp

Nasdaq:UTHR

UTHR Rankings

UTHR Stock Data

10.81B
43.37M
1.72%
97.02%
4.08%
Pharmaceutical Preparation Manufacturing
Manufacturing
Link
US
Silver Spring

About UTHR

united therapeutics corporation is a biotechnology company focused on the development and commercialization of unique products to address the unmet medical needs of patients with chronic and life-threatening conditions. we currently have five approved products on the market, and a long-term mission of providing an unlimited supply of transplantable organs for those who need them! our employees can be found collaborating across the united states, europe and asia. as a group, we are relentless in our pursuit of “medicines for life” and continue to research and develop treatments for cardiovascular and pulmonary diseases, pediatric cancers, and other orphan diseases. #weareunitherians